Nationally Noted UC San Diego Allergist Elected ABAI President, 2010

 

September 02, 2008  |  

Stephen I. Wasserman, M.D., to Serve as President-Elect

The American Board of Allergy and Immunology (ABAI) announced that it has elected Stephen I. Wasserman, M.D., professor of medicine, UC San Diego School of Medicine and Director, Allergy/Immunology section, as the organization’s president-elect.  Dr. Wasserman will assume his duties as President on January, 1, 2010. 

ABAI is the entity that oversees the certification of physicians specializing in Allergy and Immunology.

As a teacher, researcher and physician, Wasserman has devoted more than 30 years of his career to the specialty of allergy and immunology.  Wasserman has worked at the University of California, San Diego since 1979, where he founded the Allergy and Immunology training program within the Department of Medicine.  From 2000 to the present, he has been listed in America’s “Top Doctors.”  Wasserman has received numerous grants for asthma research, in addition to writing and co-writing over 200 articles and book chapters.

Wasserman is also a featured doctor on the ABCNews.com “OnCallPlus” special section on asthma.  He answered various questions regarding topics such as the standard treatment of asthma, steroid use in controlling asthma, and the latest research being conducted at UC San Diego School of Medicine. 

Wasserman is a member of several professional societies including ABAI where he served as Chairman, the American Academy of Allergy, Asthma, and Immunology, where he served as president from 1998 – 1999, and the American Board of Medical Specialties, where he currently serves as Secretary/ Treasurer.  He is also certified by the American Board of Allergy and Immunology where he was elected as a Director, Secretary, Examination co-chair and served as Chairman. 

# # #

Media Contact: Kim Edwards, 619-543-6163, kedwards@ucsd.edu




Media Contact

Share This Article


Related News

2/15/2019
The Next Generation Precision Oncology Symposium, a novel meeting of industry and academic leaders in cancer science and medicine, will be held February 21, 2019 at UC San Diego Moores Cancer Center.
2/14/2019
Researchers at UC San Diego School of Medicine report that persons with schizophrenia scored lower on a wisdom assessment than non-psychiatric comparison participants, but that there was considerable ...
2/13/2019
In a randomized, controlled pilot trial published February 13, 2019 in PLOS ONE, UC San Diego School of Medicine researchers found that participants pre-treated with noninvasive vagus nerve stimulatio ...
2/12/2019
In a new study, researchers at University of California San Diego School of Medicine report that hearing impairment is associated with accelerated cognitive decline with age, though the impact of mild ...



Follow Us